Align Technology, Inc. vs Vanguard International High Dividend Yield ETF — how do they compare? Align Technology, Inc. trades at $182.25 (market cap $12.86B), while Vanguard International High Dividend Yield ETF trades at $100. The key difference: Vanguard International High Dividend Yield ETF is trading nearer its 52-week high, Align Technology, Inc. nearer its low. Which is the better fit depends on your goals.
| ALGN | VYMI | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $207.19 | $101.60 |
52-Week Low | $124.88 | $79.76 |
Enterprise Value | $11.92B | — |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
VYMI trades at $100.57, up 0.8% today, with a bullish technical signal from moving averages and neutral oscillators. The ETF offers international high-dividend exposure with a recent $1.26 dividend declared for June 2026. News coverage highlights its role in diversification and potential outperformance versus U.S. stocks over the next decade, backed by Vanguard's low 0.07% expense ratio and over 1,500 holdings.
Outlook is positive for income investors seeking global diversification and yield, with risks including currency fluctuations and regional economic volatility. Analyst sentiment favors VYMI for its sustainable dividends and valuation appeal relative to U.S. markets, though geopolitical tensions could pressure returns.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →VYMI is an index-based ETF that provides exposure to non-U.S. companies across developed and emerging markets that are characterized by high dividend yields. It tracks the FTSE All-World ex US High Dividend Yield Index, offering a diversified, low-cost way to capture international income while serving as a tactical hedge against U.S. market concentration.
Read more on VYMI →